IDEXX Laboratories, Inc. (LON:0J8P)

Market Cap	39.87B
Revenue (ttm)	3.10B +8.4%
Net Income	764.34M +18.6%
EPS	9.37 +21.6%
Shares Out	n/a
PE Ratio	52.16
Forward PE	49.00
Dividend	n/a
Ex-Dividend Date	n/a

Volume	76
Average Volume	228
Open	694.50
Previous Close	690.36
Day's Range	674.63 - 695.73
52-Week Range	351.94 - 771.52
Beta	1.67
RSI	43.98
Earnings Date	Feb 2, 2026

About IDEXX Laboratories

IDEXX Laboratories, Inc. develops, manufactures, and distributes products for the companion animal veterinary, livestock and poultry, dairy, and water testing industries in the United States and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It offers in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, cytology, and coagulation analyzers; and SNAP rapid assays test kits. The company also provides commercial reference...

• Industry: Medical - Equipment & Services
• Sector: Healthcare
• Founded: 1983
• Employees: 11,000
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0J8P

Financial Performance

In 2024, IDEXX Laboratories's revenue was $3.90 billion, an increase of 6.46% compared to the previous year's $3.66 billion. Earnings were $887.87 million, an increase of 5.07%.

Financial numbers in USD